100 related articles for article (PubMed ID: 10763409)
21. [Celecoxib].
Fux R; Mörike K; Gleiter CH
Dtsch Med Wochenschr; 2002 Apr; 127(15):803-4. PubMed ID: 11951138
[No Abstract] [Full Text] [Related]
22. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous reaction to oral celecoxib with positive patch test.
Alonso JC; Ortega JD; Gonzalo MJ
Contact Dermatitis; 2004 Jan; 50(1):48-9. PubMed ID: 15059110
[No Abstract] [Full Text] [Related]
24. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
Wolfe F; Zhao S; Pettitt D
J Rheumatol; 2004 Jun; 31(6):1143-51. PubMed ID: 15170928
[TBL] [Abstract][Full Text] [Related]
25. Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States.
Goldstein JL; Zhao SZ; Burke TA; Palmer R; von Allmen H; Henderson SC
Am J Gastroenterol; 2003 Dec; 98(12):2627-34. PubMed ID: 14687808
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with celecoxib and rofecoxib utilization.
Rawson NS; Nourjah P; Grosser SC; Graham DJ
Ann Pharmacother; 2005 Apr; 39(4):597-602. PubMed ID: 15755796
[TBL] [Abstract][Full Text] [Related]
27. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
Liccardi G; Salzillo A; Piccolo A; Senna G; Piscitelli E; D'Amato M; D'Amato G
Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):50-3. PubMed ID: 15859361
[TBL] [Abstract][Full Text] [Related]
28. Coxibs and cardiovascular risk.
Allen MJ; McLean-Veysey P; Fleming I
CMAJ; 2005 Oct; 173(8):853. PubMed ID: 16217098
[No Abstract] [Full Text] [Related]
29. Does celecoxib use increase the risk of cardiovascular events?
Oviedo JA; Schroy PC
Gastroenterology; 2005 Oct; 129(4):1348-50. PubMed ID: 16230088
[No Abstract] [Full Text] [Related]
30. [Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered].
MMW Fortschr Med; 2003 Mar; 145(10):60. PubMed ID: 12688036
[No Abstract] [Full Text] [Related]
31. The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials.
Soni P; Shell B; Cawkwell G; Li C; Ma H
Curr Med Res Opin; 2009 Aug; 25(8):1841-51. PubMed ID: 19530981
[TBL] [Abstract][Full Text] [Related]
32. [Nephrotic syndrome associated to celecoxib].
Sirvent AE; Enríquez R; Amorós F; Reyes A
Nefrologia; 2005; 25(1):81-2. PubMed ID: 15789542
[No Abstract] [Full Text] [Related]
33. Pfizer: Celebrex increases heart attack risk.
Health News; 2005 Feb; 11(2):2. PubMed ID: 15732142
[No Abstract] [Full Text] [Related]
34. Pseudoporphyria induced by celecoxib in a patient with juvenile rheumatoid arthritis.
Cummins R; Wagner-Weiner L; Paller A
J Rheumatol; 2000 Dec; 27(12):2938-40. PubMed ID: 11128692
[No Abstract] [Full Text] [Related]
35. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
Huang WF; Hsiao FY; Wen YW; Tsai YW
Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
[TBL] [Abstract][Full Text] [Related]
36. Fatal allergic vasculitis associated with celecoxib.
Schneider F; Meziani F; Chartier C; Alt M; Jaeger A
Lancet; 2002 Mar; 359(9309):852-3. PubMed ID: 11897288
[TBL] [Abstract][Full Text] [Related]
37. [Lower gastrointestinal hemorrhage associated with celecoxib].
Serrano Pozo A; Jara Palomares L; Fuentes Rodríguez F; Calderón Sandubete E
An Med Interna; 2003 Sep; 20(9):497. PubMed ID: 14755912
[No Abstract] [Full Text] [Related]
38. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
White WB; West CR; Borer JS; Gorelick PB; Lavange L; Pan SX; Weiner E; Verburg KM
Am J Cardiol; 2007 Jan; 99(1):91-8. PubMed ID: 17196469
[TBL] [Abstract][Full Text] [Related]
39. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
Bensen WG; Zhao SZ; Burke TA; Zabinski RA; Makuch RW; Maurath CJ; Agrawal NM; Geis GS
J Rheumatol; 2000 Aug; 27(8):1876-83. PubMed ID: 10955327
[TBL] [Abstract][Full Text] [Related]
40. [Severe cutaneous drug reactions to celecoxib (Celebrex)].
Marquès S; Milpied B; Foulc P; Barbarot S; Cassagnau E; Stalder JF
Ann Dermatol Venereol; 2003 Nov; 130(11):1051-5. PubMed ID: 14724542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
